Big data can give Life Sciences firms a big edge

The pharmaceutical and life sciences industry has been flooded with data. Generated by the proliferation of personal medical devices, social media, and electronic medical records, “big data” has the potential to transform the industry — but only if companies can translate it into actionable business intelligence. Our 2014 global data and analytics survey shares how pharmaceuticals and life sciences executives using data and analytics to make decisions for their organizations.
 

    Life sciences companies need to derive value from volume

    The plethora of newfound data made available by modern technologies and generated directly by consumers can give manufacturers valuable insight into how patients are using their products. This information can help pharmaceutical and life sciences companies give payers the real-worldevidence they demand to prove the efficacy and value of new drugs and devices. The challenge lies not in collecting this data, but in harnessing, parsing, and analyzing it to create competitive advantage. Insights and intelligence derived from fast-moving data sets can help inform strategy decisions, spur innovation, inspire new products, enhance customer relationships, and bolster operations.

    Data and analytics help healthcare executives

    Highly data-driven healthcare companies are making better business decisions. We look at how data and analytics can make a difference when it comes to the most significant decisions about the strategic direction of your business. Download our pharma and life sciences data & analytics infographic.

     

    Contacts

    Risk and compliance analytics
     

    PwC's advanced risk and compliance analytics practice can help you mitigate risk and increase efficiency in a complicated regulatory environment. Learn more.

    Dan Garrett

    US health IT practice leader,
    Tel: +1 (610) 256 2055
    Dan Garrett
    US health IT practice leader,
    Tel: +1 (610) 256 2055
    Dan Garrett
    US health IT practice leader,
    Tel: +1 (610) 256 2055

    Carlos Moreira

    Principal, US pharma and life sciences
    +1 (267) 330 2580